Back to search

Netherlands· NL-2d67fd44f540

Axumin 3200 MBq/ml oplossing voor injectie

A fluciclovine (18f) product containing fluciclovine [18f], registered in Netherlands by Blue Earth Diagnostics Ireland Ltd. The same ATC class is registered in 10 of our 19 countries.

ATC V09IX12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAxumin 3200 MBq/ml oplossing voor inj…ATCV09IX12REGISTER NO.NL-2d67fd44f540PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluciclovine (18f) is registered in 10 of 19 countries.

Countries holding a registration under ATC V09IX12 (fluciclovine (18f)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Fluciclovine (18f) · ATC V09IX12

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUCICLOVINE [18F]
Manufacturer
Blue Earth Diagnostics Ireland Ltd
Country
Netherlands (NL)
ATC code
V09IX12
ATC class
Fluciclovine (18F)
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1186

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluciclovine (18f) in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluciclovine (18f) products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Radelumin
  • Belgium · Radelumin
  • Germany · Radelumin
  • Spain · Radelumin
  • France · Radelumin
  • Greece · Próstalumin
  • Iceland · Axumin
  • Italy · Radelumin
  • Liechtenstein · Axumin
  • Luxembourg · Radelumin
  • Norway · Axumin
  • Poland · Radelumin
  • Portugal · Radelumin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6f129ef-1ed4-4311-971b-100cc72b387c
GET /v1/drugs/c6f129ef-1ed4-4311-971b-100cc72b387c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/axumin-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Fluciclovine (18F)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp118634",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FLUCICLOVINE [18F]"
  ],
  "leaflet_url": null,
  "authorised_at": "2017/05/22",
  "procedure_number": "EMEA/H/C/004197",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1186",
  "additional_monitoring": "N"
}

See everything about fluciclovine (18f).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.